资讯

Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...
The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide ... 25% body weight loss compared to ...
A clinical trial showed that Lilly's weight loss medicine is superior to a key competitor's product. Eli Lilly (NYSE: LLY) is ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a ...
along with Novo Nordisk's newly forged alliances with three leading telehealth companies to drive self-pay sales of its weight loss drug. Zepbound growth has outpaced Wegovy in recent months ...
A new government-issued report reflects some of the most controversial views on vaccines, the nation’s food supply, pesticides and prescription drugs held by Health and Human Services Secretary ...
Attorney General Dave Sunday is warning Pennsylvanians to make sure they're using licensed pharmacies for GLP-1 drugs amid a growing counterfeit market.
A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...
You can help your dog maintain a healthy weight by feeding them the best dog food for weight loss. In addition, veterinarians recommend portion control and age-appropriate exercise. If your pup ...
There has been meteoric demand for the weight loss drug Wegovy since it was approved in the UK in 2023, fuelled by eye-popping trial results that revealed obese patients lost an average of 15 ...